Technology in Cancer Research & Treatment · 2017 · 72 citations · 20 references
MedicineGeneticsOncologyCarcinogenesisGene ExpressionMolecular OncologyCancer ProgressionMalignant NeoplasmsNeoplastic TransformationOncogenic ProliferationPancreatic CancerPancreatic DiseasesCancer Cell MigrationEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersMesenchymal TransitionOncogenic DysregulationP21 Regulation
BACKGROUND AND AIM: Long noncoding RNA-plasmacytoma variant translocation 1 is identified to be highly expressed and exhibits oncogenic activity in a variety of human malignancies, including pancreatic cancer. However, little is known about the overall biological role and mechanism of plasmacytoma variant translocation 1 in pancreatic cancer so far. In this study, we investigated the effect of plasmacytoma variant translocation 1 on pancreatic cancer cell proliferation and migration as well as epithelial-mesenchymal transition. METHODS: Pancreatic cancer tissue specimens and cell line were used in this study, with normal tissue and cell line acting as control. RESULTS: It showed that plasmacytoma variant translocation 1 expression was significantly upregulated in pancreatic cancer tissues or cell line compared to normal groups. Plasmacytoma variant translocation 1 downregulation significantly inhibited zinc finger E-box-binding protein 1/Snail expression but promoted p21 expression, and it also inhibited the cell proliferation and migration. Additionally, p21 downregulation enhanced, and p21 overexpression repressed, zinc finger E-box-binding protein 1/Snail expression and cells proliferation in PANC-1 cells. However, p21 downregulation reversed the effect of plasmacytoma variant translocation 1 downregulation on zinc finger E-box-binding protein 1/Snail expression and cell proliferation and migration. CONCLUSION: Plasmacytoma variant translocation 1 promoted epithelial-mesenchymal transition and cell proliferation and migration through downregulating p21 in pancreatic cancer cells.
20
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text